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Decavanadate produces extensive ordered arrays of Ca 2+-ATPase molecules on sarcoplasmic reticulum 
(SR) vesicle surfaces [(1984) J. Bioenerg. Biomembranes 16, 491-505] and the basic unit of these crystalline 
structures seems to be a dimer of Ca 2 +-ATPase [(1983) J. Ultrastruct. Res. 24, 454-464; (1984) J. Mol. Biol. 
174, 193-204]. Myotoxin a, isolated from the venom of the prairie rattlesnake Crotalus viridis viridis, is a 
muscle-degenerating polypeptide and its primary site of interaction is the SR membrane, where it uncouples 
CaZ+-translocation from CaZ+-dependent ATP hydrolysis [(1986) Arch. Biochem. Biophys. 246, 90 97]. 
The effect of myotoxin a on decavanadate-induced two-dimensional Ca 2 +-ATPase crystals of SR mem- 
branes has been investigated. The toxin inhibits the formation of two-dimensional SR-membrane crystals 
and disrupts previously formed crystals in a time- and concentration-dependent manner, which parallels 
the uncoupling of ATP hydrolysis from Ca 2 + translocation. Two-dimensional crystalline arrays of the SR 
membrane have a typical diffraction pattern which, after myotoxin a treatment, displays a progressive loss 
of order. Decavanadate is an uncompetitive inhibitor of the Ca 2 +-ATPase enzyme-myotoxin a complex. 
The present results uggest that a Ca / +-ATPase dimer is required for coupling Ca 2 + translocation to Ca 2 +- 
dependent ATP hydrolysis. 
Enzyme crystallization; Ca 2 +-ATPase; Myotoxin a; Vanadate; Enzyme inhibition 
1. INTRODUCTION 
The SR of  skeletal muscle is an endomembrane 
system that controls the myoplasmic Ca 2+ concen- 
tration and, thus, regulates contraction and relaxa- 
tion. Active transport into the SR lumen, i.e. 
muscle relaxation, is mediated by an ATP-depen- 
dent CaZ+-ATPase (Ca 2+ pump), an intrinsic mem- 
brane protein with an Mr of  about 115000 [5]. 
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Transition between two configurational states of  
the CaZ+-ATPase (EP~ and EP2) is involved in the 
Ca z+ transport cycle [6]. Important yet unsettled 
issues are whether the CaZ+-ATPase is present in 
the membrane as an oligomer both in the resting 
state and during the CaZ+-transport cycle, and 
whether the oligomeric state changes during such a 
cycle. A related question is whether the oligomeric 
state of  the CaZ+-ATPase influences the coupling 
of  Ca z+ uptake to CaZ+-dependent ATP  hydro- 
lysis. Hymel et al. [7] reported that the Ca 2+- 
ATPase is a constant dimer during the catalytic 
cycle, whereas Dux et al. [8] and Dux and Mar- 
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tonosi [9] suggested that the EP1-EP2 transition in- 
volves a shift in the monomer-oligomer 
equilibrium of the Ca2+-ATPase. Based on the 
cDNA-deduced sequence of the CaZ+-ATPase [5] a 
mechanistic model for Ca z+ translocation has also 
been proposed [10] in which an ATPase monomer 
seems to be sufficient for Ca 2+ translocation. 
However, the degree of Ca 2 +-binding cooperativity 
[11,12] would require interaction of four binding 
domains corresponding to two CaZ+-ATPase 
molecules and this implies that ATPase dimers per- 
mit full reactivity of the sites of each monomer. 
Therefore, it is not yet clear whether a dimer or a 
monomer of the Ca 2+ pump is required for Ca 2+ 
translocation. 
If  the polyanion decavanadate is added to 
purified SR vesicles, two-dimensional crystals are 
formed [1]. The CaZ+-ATPase, locked in the EP2 
configuration, is present as a dimer in these mem- 
brane crystals [2,3]. Decavanadate induces sub- 
stantial immobilization or aggregation of the 
CaZ+-ATPase molecules in native membranes [13] 
and seems to act as a nonfunctional substrate 
analogue [14]. In scallop SR two-dimensional 
membrane crystals are found without the addition 
of vanadate and the crystalline Ca2+-ATPase is 
present as a dimer [15,16]. 
The snake venom myotoxin a, a polypeptide of 
43 amino acid residues isolated from the prairie 
rattlesnake Crotalus viridis viridis [17] causes mus- 
cle degeneration [18]. Microscopic studies have 
shown that myotoxin a binds to the myoplasmic 
face of the SR [19] and causes SR vacuolization 
and later degeneration of myofibrils [20]. We have 
recently shown that myotoxin a inhibits Ca 2+ 
loading and stimulates CaZ+-dependent ATPase 
activity of isolated SR vesicles [4]. Since the mem- 
brane integrity of the SR vesicles and unidirec- 
tional Ca 2+ efflux are not affected, myotoxin a 
seems to be a true uncoupler of the Ca 2+ pump. 
We report here the effects of myotoxin a on 
decavanadate-induced two-dimensional membrane 
crystals and show that the destruction of the 
crystals by the toxin is, like the inhibition of Ca 2+ 
loading and the stimulation of the CaZ+-dependent 
ATPase, time- and concentration-dependent. We 
also provide additional evidence that myotoxin a 
interacts with the CaZ+-ATPase and not with SR 
phospholipids. The excellent correlation between 
uncoupling of Ca 2+ transport [4] and effects on 
decavanadate-induced two-dimensional membrane 
crystals leads to the suggestion that CaZ+-ATPase 
dimers are needed to have a coupled Ca z+ 
transport cycle. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Sodium vanadate was obtained from Aldrich. 
Deoxycholic acid (sodium salt) was from Sigma (St 
Louis, MO) and recrystallized twice before use. 
Pyruvate kinase, phosphoenolpyruvate, lactic 
dehydrogenase, phosphatidylcholine, and phos- 
phatidylethanolamine (from egg yolk) were also 
from Sigma. All other reagents were of analytical 
grade. 
2.2. Isolation of myotoxin a
Myotoxin a was isolated and purified from the 
venom of Crotalus viridis viridis [ 18]. Homogenei- 
ty of each preparation was established by disc gel 
electrophoresis and by analytical isotachophoresis. 
2.3. Isolation of SR vesicles 
SR vesicles were isolated and purified from rab- 
bit fast twitch skeletal muscle by differential and 
sucrose density gradient centrifugation [21]. The 
fraction referred to as R2 (mainly derived from 
longitudinal SR) was suspended in 0.3 M sucrose, 
5 mM imidazole, pH 7.4, and stored at - 70°C un- 
til used. Protein concentrations were estimated ac- 
cording to Lowry et al. [22]. Phosphorus was 
determined according to Rouser and Fleischer [23]. 
2.4. Biochemical assays 
(Mg2+-CaZ+)-ATPase was measured by a spec- 
trophotometric enzyme-coupled assay in the 
presence of 0.15 mM NADH, 0.5 mM phospho- 
enolpyruvate, 5 U pyruvate kinase and 5 U lactate 
dehydrogenase, as described [4,24]. The 
CaZ÷-dependent ATPase activity is defined as the 
difference between the total ATPase activity in the 
presence of 0.2 mM CaCI2 and basal ATPase ac- 
tivity in the presence of 0.2 mM EGTA. Ca z+- 
dependent ATPase activity was also determined by 
measuring the inorganic phosphate production 
[25]. SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) was carried out according to 
Laemmli [26]. 
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2.5. Preparation of SR-limit membranes 
SR vesicles (6 mg protein/ml) were incubated 
with deoxycholate (1 mg/ml) at 0°C for 10 min 
and then centrifuged for 25 min in a Beckman air- 
fuge A-100 rotor at 22 lb/inch 2. The pellet (SR- 
limit membranes) was resuspended in 0.3 M 
sucrose, 0.1 M KC1, 10 mM K+-Hepes, pH 7.4 [1]. 
Ca2+-ATPase represented more than 95°7o of the 
total protein as indicated by densitometry of 
Coomassie blue stained gels. 
were prepared as in [1]. Decavanadate-induced 
crystals were prepared as described in [1,4]. 
Myotoxin a was either added prior to the decava- 
nadate or after the addition of the decavanadate. 
The specimens were prepared and examined as 
described in [4]. The negatives were examined in a 
light-optical diffractometer [27]. The observed if- 
fraction patterns were then recorded on 35 mm 
film and their positions on the micrographs were 
marked with a circle. 
2.6. Preparation of liposomes 
Phosphatidylcholine and phosphatidylethanol- 
amine (1:1) were suspended in chloroform. The 
organic solvent was evaporated under a stream of 
nitrogen and the lipids were further dried under 
vacuum. After addition of 20 mM Tris and 1 mM 
EDTA, pH 8.1, the mixture was vortexed and then 
sonicated for 10 min. The liposomes were stored 
under nitrogen at 4°C until used. 
2.7. Preparation of decavanadate-induced two- 
dimensional crystals of the Ca2+-A TPase and 
electron microscopy 
Sodium vanadate and sodium decavanadate 
3. RESULTS AND DISCUSSION 
Myotoxin a has been used in the present s udy as 
a tool to investigate the oligomeric state of the 
CaZ+-ATPase during Ca 2+ translocation. The 
polyanion decavanadate induces the formation of 
two-dimensional membrane crystals of SR vesicles 
[1] which are observed by negative stain electron 
microscopy. Fig.la shows decavanadate-induced 
membrane crystals of control vesicles and fig. lb a 
sample of decavanadate-induced crystals incu- 
bated for 60 min at room temperature with myo- 
toxin a. The crystals are no longer visible after 
myotoxin a treatment but the vesicles seem to be 
Fig.1. Decavanadate-induced two-dimensional crystals of SR vesicles. For crystallization, SR vesicles (1 mg/ml) were 
incubated in 100 mM KCI, 5 mM MgCl2, 0.5 mM EGTA, 5 mM Na3VO4 and l0 mM imidazole, pH 7.4, at room 
temperature for 60 min. Negative staining electron microscopy was carried out as described in section 2. The control 
(a) shows large crystalline arrays. (b) The crystals were incubated with 0.8 mg myotoxin a per mg of SR protein. Bar 
indicates 100 nm. 
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intact (see also [4]). Many SR vesicles are still rod- 
shaped, a characteristic feature of decavanadate-  
induced two-dimensional  crystals [9]. 
Table 1 presents the time course of  the myotoxin 
a act ion on SR membrane crystals. With increasing 
incubat ion t ime, the amount  of  crystals remaining 
decreases. This decrease is concomitant  with the 
decrease of  energized Ca 2+ uptake by SR vesicles 
[4]. A lmost  all crystals are destroyed after 40 min 
of  preincubat ion.  However,  short incubat ion times 
(less than 10 min) leave most of  the crystals intact. 
Table 2 shows the concentrat ion dependence of  
myotoxin a effect on two-dimensional  SR crystals 
after 60 min preincubat ion at room temperature.  
With increasing toxin concentrat ions fewer crystals 
remain intact. The d isappearance of the decavana- 
date- induced crystals parallels the decrease of  Ca 2÷ 
loading by SR vesicles [4]. Many membrane 
crystals till remain intact at 0.05-0.1 mg myotox-  
in a per mg SR protein.  However,  higher toxin 
concentrat ions lead to rapid crystal destruct ion 
and, at 0.6 mg toxin per mg SR protein, most 
crystals are destroyed. Table 3 shows that SR 
vesicles preincubated at room temperature for 
60 min with myotoxin a concentrat ions of  0.5 mg 
Table 1 
Time course of myotoxin a action on decavanadate- 
induced two-dimensional SR membrane crystals 
Incubation time Amount of crystalline SR 
(min) (°70 of total vesicles) a 
0 (control) 50-70 
5 50-70 
10 20-40 
20 5-20 
40 no crystals visible 
60 no crystals visible 
a The percentage of crystalline vesicles is averaged from 
counting several vesicles (50-80) for each incubation 
time of two different SR preparations and 3 
crystallization experiments for each SR preparation. 
Since SR vesicles do not spread very evenly on carbon 
films in the absence of sucrose, a range is indicated for 
the percentage of crystalline vesicles. Control values 
are comparable to those previously reported [1] 
SR membrane crystals were obtained as detailed in 
section 2 and were incubated at room temperature with 
0.5 mg myotoxin a per mg SR protein 
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Table 2 
Influence of myotoxin a concentration upon 
decavanadate-induced two-dimensional SR membrane 
crystals 
[Myotoxin a] Amount of crystalline SR 
(mg per mg SR protein) (°70 of total vesicles) a 
Control 50-70 
0.05 50-70 
0.10 35-50 
0.20 10-30 
0.40 5-20 
0.60 < 5 
0.80 no crystals visible 
1.00 no crystals visible 
a See footnote to table 1 
Crystals were incubated at room temperature for 60 min 
with myotoxin a 
or 1.0 mg per mg of  SR protein,  are no longer 
capable of  forming decavanadate- induced two- 
dimensional  crystals. At  low myotoxin a concen- 
trat ions,  some crystals are still visible. 
The qual ity of  the crystals can be assessed by 
means of  d i f f ract ion studies per formed on an op- 
tical bench. Fig.2 shows the crystals and their dif- 
f ract ion patterns after incubat ion with dif ferent 
concentrat ions of  myotoxin a. The control  (panel 
a) exhibits 8 strong f irst-order eflections. The dif- 
fract ion pattern consists of  spots f rom the bot tom 
and f rom the top of  the f lattened crystal. With in- 
creasing myotoxin a concentrat ions,  the reflections 
Table 3 
Preincubation of SR vesicles with myotoxin prevents 
decavanadate-induced SR membrane crystal formation 
[Myotoxin a] Amount of crystalline SR 
(mg per mg SR protein) (°70 of total vesicles) a 
Control 50-70 
0.10 20-40 
0.50 no crystals visible 
1.00 no crystals visible 
a See footnote to table 1 
Preincubation was carried out for 60 min at room 
temperature. Membrane crystals were obtained as 
detailed in section 2. A single SR preparation was tested 
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Fig.2. Diffraction patterns of decavanadate-induced two-dimensional SR membrane crystals after treatment with 
myotoxin a. On the left side negative staining electron microscopy of decavanadate-treated SR vesicles in the absence 
(a) and presence (b,c) of myotoxin a (0.4 and 0.8 mg of myotoxin a per mg of SR). Crystallization was carried out as 
described in the legend to fig. 1. Optical diffraction patterns obtained from the images of each micrograph in the area 
enclosed by the circle are shown on the right side. The untreated sample (control, a) exhibits 8 distinct diffraction spots. 
After treatment with myotoxin a the spots become weaker, and start to disappear. Bar indicates 100 nm. 
become weaker and finally disappear. In panel b 
the diffraction pattern no longer exhibits the 4 
spots in the middle of  the pattern and only shows 
4 reflections farther out. The reflections disappear 
altogether (panel c) at 0.8 mg myotoxin a per mg 
of  SR. Since the number and the intensity of  the 
reflections increase with the quality of  the crystal, 
it can be concluded that the order of  the crystals 
decreases with increasing toxin concentrations. 
The quaternary structure of  the Ca 2+- ATPase of 
membrane crystals is a dimer [2,3], 
We have shown that binding of  specific anti-(SR 
Ca2+-ATPase) antibodies was partially blocked by 
myotoxin a [4]. In order to assess whether the 
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CaZ+-ATPase represents the predominant binding 
site of myotoxin a, a 'limit membrane' of the SR 
was formed by selective extraction with deox- 
ycholate [1]. This membrane is practically devoid 
of proteins other than the Ca2+-ATPase (see sec- 
tion 2) and the lipid-to-protein ratio decreases 
from 24 to 18/~g phosphorus/mg protein. This lat- 
ter value corresponds to 87 mol of phospholipids 
per mol Ca2+-ATPase compared to 115 mol of 
phospholipids per mol Ca2+-ATPase for native SR 
membranes. As shown in fig.3a control imit mem- 
branes still formed two-dimensional membranes. 
The treatment of such crystals with myotoxin a 
leads again to their destruction (fig.3b). 
The addition of liposomes (17.3/zg phospho- 
lipids per mg protein) to the limit-membrane, i.e. 
the equivalent amount of phospholipid present in 
1 mg of SR limit-membrane, does not inhibit 
crystal destruction by myotoxin a (not shown). The 
Ca2÷-ATPase appears to be the target site of 
myotoxin a. The toxin may induce a conforma- 
tional change by binding to the polar region of the 
Ca 2+ pump [4] and in turn lead to the disruption 
of the membrane crystals. 
Decavanadate either binds with high affinity to 
the phosphate receptor site of the Ca2+-ATPase 
[28] or interacts with both the phosphorylation site 
and the substrate site [14]. Myotoxin a might 
displace decavanadate from its site either by direct 
competition or by a shift in equilibrium in favor of 
the EP1 conformation. In order to address this 
question, vanadate and decavanadate were added 
in various concentrations both to SR and to SR 
preincubated for 60 min at room temperature with 
myotoxin a. Fig.4a shows that vanadate and 
decavanadate still inhibit the Ca2+-dependent 
ATPase activity in the presence of myotoxin a. A 
Dixon plot of the same data (fig.4b and c) indicates 
that different amounts of myotoxin a do not 
change the rate of inhibition by vanadate and 
decavanadate and that both are uncompetitive in- 
hibitors of the CaZ+-ATPase nzyme-myotoxin a 
complex. (Deca)vanadate and myotoxin a do not 
share the same binding site and crystal disruption 
is not simply caused by replacement of the 
(deca)vanadate from its binding site. Other 
vanadate-sensitive ATPases from insect brush 
border membranes and from dog kidney outer 
medulla are not affected by myotoxin a (Maurer, 
A., unpublished) and this indirectly supports our 
findings that myotoxin a does not share binding 
sites with (deca)vanadate. 
a 
Fig.3. Influence of myotoxin a on decavanadate-induced two-dimensional crystals of limit SR membranes. SR 
membranes were delipidated with deoxycholate to form limit membranes. Negative staining was carried out as described 
in section 2. 30-45°7o of the control vesicles (a) showed decavanadate-induced crystals. After treatment with 0.8 mg 
myotoxin a per mg SR at 22°C for 60 min, no more crystals were found (b). Bar indicates 100 nm. 
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Fig.4. Effect of vanadate and decavanadate on 
Ca2+-dependent ATPase activity. SR was incubated with 
increasing amounts of vanadate (open symbols) or 
decavanadate (closed symbols) and the Ca2+-ATPase 
activity was determined as described in section 2. (a) The 
controls are represented by open and closed circles and 
the myotoxin a-treated samples (0.4 mg and 1.0 mg per 
mg SR) by squares and triangles, respectively. The 
vesicles were preincubated for 60 min at 22°C with or 
without myotoxin a in 0.3 M sucrose and 5 mM 
imidazole, pH 7.4. In panels b and c the same data are 
presented in the form of a Dixon plot. Panel b shows the 
inhibition with vanadate and panel c shows the 
inhibition with decavanadate. 
In this study we show that the toxin disrupts 
decavanadate- induced two-dimensional  membrane 
crystals and that the action of  myotoxin a on these 
crystals is t ime- and concentrat ion-dependent  as 
was the inhibit ion of  Ca2÷-uptake and the st imula- 
t ion of  CaZ+-dependent ATPase  [4]. The crystals 
remaining after myotoxin a treatment exhibit a 
progressive loss of  order that is suggestive of  a con- 
format iona l  change of  the CaZ+-ATPase. Thus, 
myotox in  a alters the dimeric associat ion of  the 
CaZ+-ATPase molecules. 
The uncoupl ing of  the CaZ+-transport cycle and 
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the disruption of the decavanadate-induced SR 
crystals by myotoxin a might be due to the same 
mechanism. Assuming that decavanadate-induced 
crystalline arrays reflect physiological states of the 
CaZ+-ATPase, a plausible interpretation of the 
present data is that myotoxin a interferes with the 
dimeric association of the CaZ+-ATPase and 
causes increase of CaZ+-dependent ATP hydrolysis 
and inhibition of Ca2+-uptake. Our results imply 
that a CaZ+-ATPase dimer is needed to have cou- 
pled CaZ+-transport cycle. Additional insight into 
the molecular mechanism of myotoxin a action can 
be obtained by studying structural and configura- 
tional changes of the CaZ+-ATPase. 
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